Help make an impact on early detection with the Galleri test
As we observe World Cancer Day, we want to reaffirm our commitment to helping people live longer, healthier, better lives and remind our members of the power of early detection and preventative screenings in the fight against cancer.
We’re proud to partner with GRAIL to provide eligible Vitality PLUS clients with access to the Galleri® multi-cancer early detection test, which is designed to screen more than 50 types of cancer with a single blood draw. The Galleri test is a first-of-its-kind-blood test that screens for a fingerprint of many cancers before they become symptomatic, including those without dedicated screening tests today, such as pancreatic and liver cancers.
As a reminder, John Hancock matches every four Vitality registrations with one cancer screening donated directly to the Home Base organizations. It is widely known that special operators are at a higher risk of cancer due to exposure to chemicals, substances and other hazards during their service.**
Did you find this content helpful?
Yes
No
*Beginning Veteran's Day 2024 and running through at least July 4, 2025, for every four new Vitality registrations, John Hancock will sponsor one Galleri test which will be donated directly to Home Base.
**American Cancer Society: www.cancer.org/cancer/veterans.html
FOR AGENT USE ONLY. THIS MATERIAL MAY NOT BE USED WITH THE PUBLIC.
Galleri is a blood test from Grail designed to screen for cancer. The Galleri test does not detect all cancers nor does it diagnose cancer. A test result of “Cancer Signal Detected” requires confirmatory diagnostic evaluation by medically established procedures (e.g., imaging) to confirm cancer. There may be additional costs for such diagnostic testing. Rx only. It is intended to be used in addition to, and not replace, other cancer screening tests recommended by a healthcare provider. A negative test result does not rule out cancer and in particular the sensitivity rate for detecting cancer in the early stages is lower than for later stages. A false positive or false negative result can occur and results should be discussed with a healthcare provider. Test eligibility is subject to certain qualification requirements, including age and certain health risk factors. There is no coordination between John Hancock and any health benefits you may receive from an insurance policy, health plan, or any other wellness programs you may be enrolled in.
Like other medical tests you elect, a decision to take the Galleri test, and the results of the test, may need to be disclosed in an application for insurance coverage, unless prohibited by law, and so could affect your access to future insurance coverage and the price of such coverage.
John Hancock is not an affiliate of GRAIL. The Galleri test is manufactured and distributed by GRAIL. John Hancock does not provide medical advice, is not involved in the design or manufacture of the Galleri test and is not responsible for the accuracy or performance of the Galleri test. Galleri is not a test to confirm or rule out genetic or other conditions that may indicate a predisposition to cancer. The Galleri test is currently not approved by the U.S. Food and Drug Administration.
The tax treatment of the Galleri test offered in connection with the Vitality Program is uncertain. At this time, John Hancock does not expect that it will be required to report the value of the Galleri test to the IRS as income to the insured. This material does not constitute tax or legal advice and neither John Hancock nor any of its agents, employees or registered representatives are in the business of offering such advice. You should consult your own tax professional.
The Galleri test is only available to registered John Hancock Vitality PLUS members who are 40 years of age or older and have completed the Vitality Health Review (VHR) for the current program year. For eligible polices with Face Amounts of $500,000 or greater in life insurance coverage, 100% of the cost of the test will be subsidized. For policies with Face Amounts less than $500,000 in life insurance coverage, 50% of the cost of the test will be subsidized. Test eligibility is also subject to Grail’s clinically informed criteria, as well as additional cancer risk factors for those ages 40-49. Please note: for members with multiple policies, the policy with the highest Face Amount in life insurance coverage will determine the subsidy amount of the Galleri offer.
Access to the Galleri test through the John Hancock Vitality Program is not currently available in all states. The offer of discounted access to the Galleri test is subject to change.
Vitality is the provider of the John Hancock Vitality Program in connection with policies issued by John Hancock.
Insurance policies and/or associated riders and features may not be available in all states.
Insurance products are issued by: John Hancock Life Insurance Company (U.S.A.), Boston, MA 02116 (not licensed in New York) and John Hancock Life Insurance Company of New York, Valhalla, NY 10595.
